<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28099604</article-id>
      <article-id pub-id-type="pmc">5193193</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164628</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dermatopathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Granuloma faciale: clinical, morphological and immunohistochemical
aspects in a series of 10 patients<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Cristiano Claudino</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ianhez</surname>
            <given-names>Pedro Eug&#xEA;nio de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Silvio Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Mari&#xE2;ngela Esther Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Universidade Estadual Paulista "J&#xFA;lio de Mesquita Filho"
(Unesp) &#x2013; Botucatu (SP), Brazil</aff>
      <aff id="aff2"><label>2</label> Hospital Ipiranga &#x2013; S&#xE3;o Paulo (SP), Brazil</aff>
      <author-notes>
        <corresp id="c1"><bold>Mailing address:</bold> Cristiano Claudino Oliveira,
Department of Pathology, Universidade Estadual Paulista "J&#xFA;lio de
Mesquita Filho", Botucatu School of Medicine, Distrito de Rubi&#xE3;o
J&#xFA;nior, s/n&#xBA; - Botucatu, 18618-970 - S&#xE3;o Paulo - SP Brazil,
E-mail: <email>cristiano_c_oliveira@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>6</issue>
      <fpage>803</fpage>
      <lpage>807</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Granuloma faciale is a chronic, benign, cutaneous vasculitis with
well-established clinical and morphological patterns, but with an unknown
etiology. This study describes clinical and pathologic aspects of patients
diagnosed with granuloma faciale. The authors analyzed demographic, clinical,
morphological and immunohistochemical data from patients with a final diagnosis
of granuloma faciale, confirmed between 1998 and 2012. There was a proportional
and mixed inflammatory infiltrate, Grenz zones were present in almost all the
samples. Immunophenotyping confirmed a higher intensity of T lymphocytes than B
lymphocytes in thirteen samples, with a predominance of T CD8 lymphocytes in 64%
of cases, in contrast to the literature, which indicates that the major
component is T CD4 lymphocytes. All cases were positive for IgG4 but the
majority (12/14) had less than 25% of stained cells. The pathogenesis of
granuloma faciale remains poorly understood, making studies of morphological and
immunohistochemical characterization important to better understand it.</p>
      </abstract>
      <kwd-group>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Inflammation</kwd>
        <kwd>Pathology</kwd>
        <kwd>Skin</kwd>
        <kwd>Vasculitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Granuloma faciale is a chronic, benign, cutaneous vasculitis with well-established
clinical and morphological patterns, but with an unknown etiology.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> The scientific literature on this disease is composed
predominantly of case reports. The most recent case series were published by
Casinaro <italic>et al.</italic> (2013, 25 patients), Ziemer <italic>et al</italic>
(2011, 41 patients), Ortonne <italic>et al.</italic> (2005, 66 patients) and
Marcoval <italic>et al.</italic> (2004, 11 patients)<sup><xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r6" ref-type="bibr">6</xref></sup>, while the
Brazilian literature lacks granuloma faciale case series.</p>
      <p>Studying clinical and histopathological manifestations may be a way to clarify the
variables that influence the disease's onset and course. This study discusses cases
of Brazilian patients diagnosed with granuloma faciale at a health referral service,
characterizing the clinical, epidemiological, histopathological and
immunohistochemical features of the lesions.</p>
    </sec>
    <sec sec-type="methods">
      <title>METHODS</title>
      <p>This is a descriptive, cross-sectional and retrospective study, developed at the
Department of Pathology, <italic>Universidade Estadual Paulista "J&#xFA;lio de
Mesquita Filho"</italic>, Botucatu School of Medicine (Unesp). It was approved
by the local Ethics Committee.</p>
      <p>The histopathology reports file was reviewed for the period encompassing January 1998
(the beginning of digital files) to April 2012, and ten patients with a histological
diagnosis of granuloma faciale were identified.</p>
      <p>Patients diagnosed with granuloma faciale during this period had their lesion
biopsies reviewed by two pathologists. The samples were characterized by lesion
location and the specific morphological patterns described in the literature. The
inflammatory cell population, analyzed by Hemotoxylin &amp; Eosin (H&amp;E)
staining, was quantitatively measured using a grading scale as specified
cellularity: from 0 to 25%, 26% to 50%, 51% to 75% and 76% to 100%.</p>
      <p>The characterization of the immunophenotypic profiles in inflammatory processes was
performed by immunohistochemistry reactions using the following antibodies: CD3
(policlonal, dilution 1:150, source Cell Marque), CD20 (clone L26, dilution 1:250,
source Cell Marque), CD4 (clone SP35, dilution 1:100 source Cell Marque), CD8 (clone
C8/144B, dilution 1:200, source Cell Marque), immunoglobulin G (IgG) (polyclonal,
dilution 1:250, source Cell Marque) and immunoglobulin G4 (IgG4) (clone MRQ-44,
dilution 1:250, source Cell Marque). The percentage of cells stained by each
antibody was analyzed through the grading scale described above. The cutoff criteria
for identifying IgG4-delated disease were: presence of 50 or more stained plasma
cells by IgG4 per high-power field (HPF) and an IgG4/IgG ratio higher than 40%.</p>
      <p>Demographic data and medical history were collected from medical records, tabulated
and submitted for descriptive analysis.</p>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <p>Between 1998 and 2012, the authors identified 10 patients with granuloma faciale,
four of which had had two manifestations in two different years. Most patients (60%)
were female and age ranged between 36 and 59 years. Regarding comorbidities, four
patients were smokers, and some had hypertension (n = 1), diabetes mellitus (n = 1),
dyslipidemia (n = 1), systemic lupus erythematosus (n = 1) and cutaneous malignant
epithelial tumors (n = 2). No relationship was found between the lesions and local
trauma, though one patient's lesion was near a surgical scar (<xref ref-type="table" rid="t1">Table 1</xref>).</p>
      <table-wrap id="t1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Patients diagnosed with granuloma faciale by biopsy between 1998 and 2012</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col width="16%" span="1"/>
            <col width="16%" span="1"/>
            <col width="16%" span="1"/>
            <col width="16%" span="1"/>
            <col width="16%" span="1"/>
            <col width="16%" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Patient</th>
              <th align="left" rowspan="1" colspan="1">Number <break/>of biopsies</th>
              <th align="left" rowspan="1" colspan="1">Gender</th>
              <th align="left" rowspan="1" colspan="1">Age</th>
              <th align="left" rowspan="1" colspan="1">Comorbidity</th>
              <th align="left" rowspan="1" colspan="1">Smoker</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">Two</td>
              <td align="left" rowspan="1" colspan="1">M</td>
              <td align="left" rowspan="1" colspan="1">54</td>
              <td align="left" rowspan="1" colspan="1">DM</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Two</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">36</td>
              <td align="left" rowspan="1" colspan="1">Absent</td>
              <td align="left" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">Two</td>
              <td align="left" rowspan="1" colspan="1">M</td>
              <td align="left" rowspan="1" colspan="1">54</td>
              <td align="left" rowspan="1" colspan="1">NMEC</td>
              <td align="left" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">
                <xref ref-type="table-fn" rid="TFN1">*</xref>
              </td>
              <td align="left" rowspan="1" colspan="1">Absent</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">5</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">M</td>
              <td align="left" rowspan="1" colspan="1">59</td>
              <td align="left" rowspan="1" colspan="1">NMEC</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Two</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">55</td>
              <td align="left" rowspan="1" colspan="1">HAS</td>
              <td align="left" rowspan="1" colspan="1">Yes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">41</td>
              <td align="left" rowspan="1" colspan="1">LES</td>
              <td align="left" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">8</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">M</td>
              <td align="left" rowspan="1" colspan="1">48</td>
              <td align="left" rowspan="1" colspan="1">Absent</td>
              <td align="left" rowspan="1" colspan="1">No</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">9</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">
                <xref ref-type="table-fn" rid="TFN1">*</xref>
              </td>
              <td align="left" rowspan="1" colspan="1">Absent</td>
              <td align="left" rowspan="1" colspan="1">
                <xref ref-type="table-fn" rid="TFN1">*</xref>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">One</td>
              <td align="left" rowspan="1" colspan="1">F</td>
              <td align="left" rowspan="1" colspan="1">53</td>
              <td align="left" rowspan="1" colspan="1">Absent</td>
              <td align="left" rowspan="1" colspan="1">
                <xref ref-type="table-fn" rid="TFN1">*</xref>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <label>*</label>
            <p>Information not available; DM=diabetes mellitus; HAS=hypertension;
LES=systemic lupus erytematosus; NMEC=non-melanoma cutaneous malignant
epithelial tumors.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>All patients had facial lesions, mostly in the nasal, malar and zygomatic regions.
The clinical aspect of the lesions varied from macules to papules and plaque, and
most patients presented with more than one lesion (<xref ref-type="fig" rid="f1">Figure 1</xref>). Telangiectasis (n = 1) and pruritus ( n = 1) were reported in
clinical interviews.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Granuloma Faciale. Clinical photos (A &#x2013; patient 6; B &#x2013; patient 2)
exemplifying facial involvement by erythematous plaques. In this study, all
patients had lesions on the face</p>
          </caption>
          <graphic xlink:href="abd-91-06-0803-g01"/>
        </fig>
      </p>
      <p>Histopathological analysis revealed the presence of a Grenz zone in most samples,
both in the epidermis and perifolicular region (12 /14). The irregularity of the
perifollicular Grenz zone was also observed in four cases, and in one of them this
change was also seen in the epidermis. In all cases, a perivascular mixed
inflammatory infiltrate of lymphocytes, plasma cells, eosinophils and neutrophils
was observed. Most samples (8/14) had a balanced ratio between cellular inflammatory
elements. In other cases (6/14), a more pronounced neutrophil population was noticed
(<xref ref-type="fig" rid="f2">Figure 2</xref>). In 13 samples, there was a
perivascular inflammatory infiltrate and permeation of the vascular wall, sometimes
with fibrinoid degeneration, comprising a vasculitis pattern, typical in granuloma
faciale. In one sample, the inflammatory process was diffuse throughout the dermis.
A biopsy showed areas of fibrosis adjacent to the perivascular inflammation.</p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Granuloma Faciale. Pictures A (H&amp;E, 100x) and B (H&amp;E, 200x), showing
the Grenz zone and perivascular inflammatory infiltrate composed of
neutrophils, eosinophils, lymphocytes and plasma cells. Immunohistochemical
images showing a predominance of T lymphocytes (C, CD3, 200x) compared with
B lymphocytes (D, CD20, 200x). Pictures E (IgG, 200x) and F (IgG4, 200x)
reveal no pattern of IgG4-related disease. There was a higher proportion of
T CD8 lymphocytes (H, 200x) than T CD 4 lymphocytes (G, 200x)</p>
          </caption>
          <graphic xlink:href="abd-91-06-0803-g02"/>
        </fig>
      </p>
      <p>Evaluation by immunohistochemical reaction confirmed a predominance of T lymphocytes
compared with B lymphocytes, in 13 samples. The proportion of cells staining by CD3
was higher than 75% in cellularity compared with the CD20 ratio. The population of T
lymphocytes was also evaluated by immunostaining for CD4+ and CD8+ cells, indicating
a predominance of CD8+ T cells, assessed in 64% of the biopsies. The evaluation
revealed positive IgG immunostaining in all cases studied at a variable rate of
25-75% cellularity. IgG4 was expressed by fewer than 50 plasma cells per HPF in all
samples (<xref ref-type="fig" rid="f2">Figure 2</xref>). Thus, there were no
criteria for diagnosing IgG4-related disease in any of the samples.</p>
      <p>Seven patients underwent clinical treatment with topical corticoids but only in one
case long-teerm resolution was observed. (<xref ref-type="table" rid="t2">Table
2</xref>). One patient treated with photodynamic therapy (PDT) relapsed after
three years and one patient experienced spontaneous resolution.</p>
      <table-wrap id="t2" orientation="portrait" position="float">
        <label>Table 2</label>
        <caption>
          <p>Patients diagnosed with granuloma faciale who had undergone clinical
treatment</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Patient</th>
              <th align="left" rowspan="1" colspan="1">Drug</th>
              <th align="center" rowspan="1" colspan="1">Electrocoagulation</th>
              <th align="left" rowspan="1" colspan="1">Clinical follow-up</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">Topical corticoid + Dapsone</td>
              <td align="center" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Relapse after four years</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">Topical corticoid</td>
              <td align="center" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Relapse after three years</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">6</td>
              <td align="left" rowspan="1" colspan="1">Topical corticoid + Dapsone</td>
              <td align="center" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Relapse after two years</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">Topical corticoid</td>
              <td align="center" rowspan="1" colspan="1">Yes</td>
              <td align="left" rowspan="1" colspan="1">Clinical success</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">Topical corticoid</td>
              <td align="center" rowspan="1" colspan="1">No</td>
              <td align="left" rowspan="1" colspan="1">
                <xref ref-type="table-fn" rid="TFN2">*</xref>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <label>*</label>
            <p>Information not available.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Although the literature reports that granuloma faciale is more common in males,
appearing between the second and seventh decades of life,<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> our series of 10 patients revealed a predominance of women,
while the age range included the interval between the fourth and sixth decades of
life. Lesions are described primarily in the regions exposed to light, as plaques or
papules, single or multiple, usually with an erythematous appearance.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> The face is predominantly
affected, as observed in this study. <sup><xref rid="r11" ref-type="bibr">11</xref></sup> Extra-facial lesions are reported in the literature, some of
them concurrent to the facial lesions.<sup><xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r11" ref-type="bibr">11</xref></sup> In a study by Thiyanaratnam <italic>et
al.</italic> (2009), the authors reported that 90% of the lesions began on the
face.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> The disease has a
slow and progressive course and may provoke symptoms of itching and telangiectasias,
evolving with periods of exacerbation and remission. The differential diagnosis
includes rosacea, lupus erythematosus, sarcoidosis and infectious granulomatous
diseases.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup></p>
      <p>Erythema elevatum diutinum (EED) is an important differential diagnosis for granuloma
faciale, especially in its extra-facial presentation. Both lesions are
leukocytoclastic vasculitis variants. The main differences between the two entities
are clinical, so the atypical locations pose greater diagnostic difficulties. EED
manifests with multiple lesions on the extensor surface of the joints. Granuloma
faciale manifests in isolation, predominantly on the face. As regards morphology,
there is an overlap of histopathological findings. Some authors highlight that EED
has a major fibrosis component and that granuloma faciale has more inflammatory
infiltrate with the Grenz zone. However, it is known that these changes present in a
very similar pattern in two entities, not being sufficient for
differentiation.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> All the
patients in this study had facial lesions. Most samples entailed a typical,
perivascular, inflammatory pattern. Fibrosis was detected in only one biopsy.</p>
      <p>The etiology of granuloma faciale is still poorly understood.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> Thiyanaratnam <italic>et al.</italic> (2009) reported sun
exposure and previhad a history of local trauma due to surgery to remove skin
cancer.</p>
      <p>Histopathological examination is an essential feature for diagnosing this entity and
it is characterized by a dense, perivascular, mixed, inflammatory pattern,
consisting of neutrophils, eosinophils, plasma cells and lymphocytes.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup> CD4 +
lymphocytes are referenced as important cells in the pathogenesis of granuloma
faciale. Imumnophenotypic analysis reveals a predominance of CD4 + lymphocytes,
responsible for producing interferon-gamma, a mediator which acts to express
molecules such as ICAM-1 on the surface of keratinocytes, promoting the chemotaxis
of lymphocytes.<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> Interestingly, in granuloma faciale lesions, basal
keratinocytes do not express ICAM-1, restricting the migration of inflammatory cells
into the epidermis, forming the characteristic Grenz zone.<sup><xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref></sup></p>
      <p>The 10 cases discussed in this study exhibited morphological patterns equivalent to
the descriptions in the literature, with mixed, diffuse and mainly perivascular
inflammatory infiltrate composed of neutrophils, eosinophils, lymphocytes and plasma
cells.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref></sup> Most
patients in this study had balanced populations of these cell types. The Grenz zone
is reported in 74% to 100% of cases of facial granuloma.<sup><xref rid="r15" ref-type="bibr">15</xref></sup> Immunohistochemical analysis of samples from this
study revealed a superiority of CD8+ T cells compared with CD4+ T lymphocytes,
differing from the current literature.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup></p>
      <p>Cesinaro <italic>et al.</italic> (2013) suggested recently that the etiology of
granuloma faciale might be linked to the IgG4-related lesions spectrum. These
authors studied 25 patients with granuloma faciale and 6 of them met the criteria
for IgG4-related disease in their biopsy. The criteria adopted were: the presence of
50 or more plasma cells stained by IgG4 and a IgG4/IgG higher than 40% evaluated in
HPF.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r16" ref-type="bibr">16</xref></sup> Immunostaining for immunoglobulins in this small
series does not confirm the suggestions proposed by Cesinaro <italic>et al.</italic>
(2013).<sup><xref rid="r3" ref-type="bibr">3</xref></sup> The positivity
criteria reported by the authors were not found in any of the biopsies studied.</p>
      <p>Because of the lack of detailed pathological mechanisms, there were no efficient
treatment protocols.<sup><xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r17" ref-type="bibr">17</xref></sup> The literature highlights surgical interventions and
clinical interventions with drugs, single or combined, or combined with therapies
such as electrocoagulation. The most commonly prescribed medications include
corticosteroids, antimalarials and dapsone.<sup><xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r14" ref-type="bibr">14</xref></sup></p>
      <p>Recently, the literature has emphasized topical tacrolimus in treating these
lesions<sup><xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r13" ref-type="bibr">13</xref></sup>, though no
patient in the study was subjected to this treatment. Tacrolimus is a macrolide
antibiotic used in transplant patients by inhibiting lymphocyte activation through
interleukins, with consequent reduction in interferon gamma levels.<sup><xref rid="r13" ref-type="bibr">13</xref></sup> Gupta <italic>et al.</italic>
(2012) reported a case of therapeutic success after three months of tacrolimus in
patients whose treatment with dapsone and corticosteroids had been
unsuccessful.<sup><xref rid="r17" ref-type="bibr">17</xref></sup></p>
      <p>Granuloma faciale is a chronic skin disease with well-established clinical and
morphological characteristics, though there is a lack of a full understanding of
their pathological mechanisms that compromise the development of effective,
therapeutic interventions. This study analyzed fourteen samples from ten patients,
documenting a predominant involvement of CD8 + T lymphocytes, a different finding to
that described in the literature, allowing for improvement in pathophysiological
understanding of this disease.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Department of Pathology, Universidade Estadual Paulista
"J&#xFA;lio de Mesquita Filho", Botucatu School of Medicine (Unesp) &#x2013; Botucatu
(SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Richaud</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Granuloma facial a prop&#xF3;sito de un caso</article-title>
          <source>Rev Cent Dermatol Pascuan</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>147</fpage>
          <lpage>150</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barreto</surname>
              <given-names>AMW</given-names>
            </name>
            <name>
              <surname>Purin</surname>
              <given-names>KSM</given-names>
            </name>
            <name>
              <surname>Fillus Neto</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Granuloma facial</article-title>
          <source>An Bras Dermatol</source>
          <year>1991</year>
          <volume>66</volume>
          <fpage>25</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cesinaro</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lonardi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Facchetti</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Granuloma Faciale - A Cutaneous Lesion Sharing Features With
IgG4-associated Sclerosing Diseases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2013</year>
          <volume>37</volume>
          <fpage>66</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">23211291</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziemer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koehler</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Weyers</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Erythema elevatum diutinum - a chronic leukocytoclastic
vasculitis microscopically indistinguishable from granuloma
faciale</article-title>
          <source>J Cutan Pathol</source>
          <year>2011</year>
          <volume>38</volume>
          <fpage>876</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="pmid">21883365</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ortonne</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wechsler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bagot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grosshans</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cribier</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale a clinicopathologic study of 66
patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2005</year>
          <volume>53</volume>
          <fpage>1002</fpage>
          <lpage>1009</lpage>
          <pub-id pub-id-type="pmid">16310061</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcoval</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peyr</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale a clinicopathological study of 11
cases</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2004</year>
          <volume>51</volume>
          <fpage>269</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">15280847</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demircioglu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>B&#xFC;k&#xFC;lmez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>G&#xF6;k&#xF6;z</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Guess what Diagnosis: granuloma faciale</article-title>
          <source>Eur J Dermatol</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>313</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">10939862</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thiyanaratnam</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Krishnan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale case report and review</article-title>
          <source>Dermatol Online</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>3</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsiung</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale</article-title>
          <source>Dermatol Online J</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>39</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">14594612</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marques</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stoff</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Giacon</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>CVB</given-names>
            </name>
            <name>
              <surname>Barsotti</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>MEA</given-names>
            </name>
          </person-group>
          <article-title>Granuloma facial a prop&#xF3;sito de dois casos</article-title>
          <source>An Bras Dermatol</source>
          <year>1997</year>
          <volume>72</volume>
          <fpage>43</fpage>
          <lpage>46</lpage>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>SRC</given-names>
            </name>
          </person-group>
          <article-title>Granuloma facial case study</article-title>
          <source>An Bras Dermatol</source>
          <year>1999</year>
          <volume>74</volume>
          <fpage>245</fpage>
          <lpage>247</lpage>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smoller</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Bortz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Immunophenotypic analysis suggests that granuloma faciale is a
g-interferon mediated process</article-title>
          <source>J Cutan Pathol</source>
          <year>1993</year>
          <volume>20</volume>
          <fpage>442</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">7507947</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jedlickov&#xE1;</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Feit</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Semr&#xE1;dov&#xE1;</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale successfully treated with topical tacrolimus a
case report</article-title>
          <source>Acta Dermatovenerol Alp Pannonica Adriat</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>34</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">18454269</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leite</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guedes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Furtado</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Baptista</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Granuloma faciale of the scalp</article-title>
          <source>Dermatol Online J</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>6</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbas</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Mahalingam</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The Grenz Zone</article-title>
          <source>Am J Dermatopathol</source>
          <year>2013</year>
          <volume>35</volume>
          <fpage>83</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">23348142</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheuk</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related sclerosing disease a critical appraisal of an
evolving clinicopathologic entity</article-title>
          <source>Adv Anat Pathol</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>303</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="pmid">20733352</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Naik</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Kar</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>Granuloma Faciale with extrafacial involvement and response to
tacrolimus</article-title>
          <source>J Cutan Aesthet Surg</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>150</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">23060713</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
